March 2, 2026 · Form 4 insider transaction
Paolini John F. bought 40,000 shares of Kiniksa Pharmaceuticals Ltd. at $10.36 per share, a transaction worth $414.4K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on November 18, 2025.